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We studied 35 patients with chronic meningitis. The neurological abnormalities included
aseptic meningitis, cranial neuropathy (mostly facial palsy), motor and sensory peripheral
radiculoneuropathy, and myelitis. Neurological symptoms were sometimes preceded by
erythema chronicum migrans or an insect bite and were often accompanied by fever, malaise,
profound fatigue, and weight loss. The cerebrospinal fluid (CSF) abnormalities consisted of a
predominantly mononuclear pleocytosis, an elevated CSF protein (mean 2.3 g/l), intrathecal
synthesis of oligoclonal immunoglobulin G, and, in half of the patients, a fall in the
CSF/blood glucose ratio. High antibody titers to the Lyme spirochete and the Swedish Ixodes
ricinus spirochete were demonstrated by immunofluorescence in 26 of the 35 patients. By im-
print immunofixation of electrofocused samples of serum and CSF, intrathecal production of
oligoclonal Lyme-spirochete-specific IgG was demonstrated in one patient with chronic men-
ingitis. Four sequential paired samples of serum and CSF from this patient showed local syn-
thesis of spirochete-specific antibodies in CSF. The 35 patients improved or recovered,
sometimes dramatically, during a two-week course of intravenous penicillin G.
INTRODUCTION
Chronic meningitis has been defined as a disease which fails to improve, or pro-
gresses both in its clinical and cerebrospinal fluid (CSF) abnormalities during a four-
week period [1,2]. It can be associated with various infectious and non-infectious
disorders. We have previously reported 21 patients with chronic meningitis, all of
whom had a similar onset and course ofdisease [3]. Except for Streptococcus milleri
antigen in the CSF in one patient, theyhad no demonstrable association with any in-
fectious disease. The patients improved or recovered after therapy with intravenous
penicillin G. In addition, all had indications ofan intrathecal immune response with
localized CSF production of oligoclonal immunoglobulin G (IgG). Since the
previous report [3] we have treated 14 additional patients with similar characteris-
tics. We report here clinical data on the 35 patients, serological examination for an-
tibodies to the Lyme spirochete and the Swedish Ixodes ricinus spirochete, and
results of imprint of immunofixation of electrofocused CSF and serum specimens.
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PATIENTS AND METHODS
Patients
Between 1975 and 1983, we studied the 35 patients in the Department of Infec-
tious Diseases, Danderyd Hospital (24 patients), in the Department of Neurology,
South Hospital, Stockholm (eight patients), and, only during 1983, in the
Roslagstull Hospital of Infectious Diseases (three patients). Chronic meningitis was
defined as a disease, which failed to improve or worsened in its clinical and CSF ab-
normalities during a four-week period.
Laboratory Investigations
Blood tests done on all patients included an erythrocyte sedimentation rate,
hemoglobin, leucocytes, alanine and aspartate aminotransferases, and creatinine.
CSF samples were analyzed for cell counts, total protein, and CSF/blood glucose
ratios. Samples of CSF, blood, nasopharynx, and urine were also cultured in many
patients. Counter-current immunoelectrophoresis was used in an attempt to detect
Streptococcus milleri antigen in CSF samples from 20 patients [4]. CSF specimens
were also investigated for Cryptococcus neoformans and its antigen in 28 patients;
for Mycobacterium tuberculosis in nine patients.
Sera from all patients were examined for antibodies against Treponemapallidum,
Listeria monocytogenes, Toxoplasma gondii, and Actinomyces israelii. Paired sera
from all patients and CSF samples from 22 patients were examined for complement-
fixing antibodies to herpes simplex virus, varicella zoster virus, cytomegalovirus,
coxsackie virus, echovirus, mumps virus, and tick-borne encephalitis virus [5].
Finally, sera from 34 patients were examined for antibodies to the Lyme spirochete
and to the Swedish I. ricinus spirochete [8].
Agarose electrophoresis in combination with immunofixation was used to ex-
amine for oligoclonal IgG bands in 122 paired CSF and serum samples from the 35
patients [6]. Before the electrophoretic separation, the CSF was concentrated about
100 times in Minicon B 15 cells (Amicon Netherlands). Albumin and IgG levels were
measured in CSF and serum samples using a nephelometric method. The IgG index
was calculated as (CSF-IgG/serum-IgG):(CSF-albumin/serum-albumin) [7]. Im-
print immunofixation (IIF) ofelectrofocused sera and CSF samples was done as de-
scribed previously [9]. Briefly, paired serum and CSF, adjusted to equivalent con-
centration ofIgG (2.5 g/l), were separated by an electrofocusing polyacrylamide gel
with a pH 6.5-9.5 gradient. Agarose gel plates containing Lyme spirochete (120
ig/ml), Treponema reiter, measles virus, or cytomegalovirus antigen (25 to 80
jig/ml) were incubated sequentially in direct (gel-to-gel) contact with the separating
gel for five minutes. Agarose gel plates without antigen were also included. After in-
cubation, the separating gel was fixed and stained. The agarosegel plates containing
antigen were washed and pressed to remove unbound antibodies, incubated in
'25I-labeled rabbit antihuman IgG overnight, washed, pressed, dried, and autoradio-
graphed for 17 hours.
RESULTS
Ofthe 35 patients with chronic meningitis, 15 were male and 20 female. Their ages
ranged from 10 to 81 years (mean, 45). Except for one patient who was in remission
from chronic myelogenous leukemia, all had previously been healthy and had not
been treated with immunosuppressive drugs. The patients had their first symptoms
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during summer or early fall (June to October). Thirteen ofthepatients had been bit-
ten by insects within a few weeks before onset ofillness, eight ofthem reported bites
by ticks, and one by a horsefly. Nine patients developed local skin reactions, which
healed spontaneously, and five patients described erythema chronicum migrans
(ECM). One ofthe latter patients had had ECM and meningitis 20 years earlier after
a tick bite on the upper right thigh.
The time between onset of symptoms and the first medical consultation ranged
from four days to 38 weeks (mean, four to five weeks). Treatment with intravenous
penicillin G (3 g every six hours for two weeks) was given 12 weeks after onset of
symptoms (range, 3-48 weeks). Most patients had clear clinical improvement within
two to five days after starting therapy.
Signs and Symptoms
The illness began slowly and was accompanied by profound fatigue, loss of ap-
petite, weight loss, migrating muscular pain, and sometimes burning and smarting
dysaesthesia and/or facial nerve paralysis (Table 1). Only two-thirds of the patients
complained ofheadache. When present, it was usually not adominant symptom and
was often periodic. Only five patients had severe headache. Two-thirds of the pa-
tients had fever, which was usually minor; only five patients had high fever.
Cranial nerve paresis developed in 16 patients. Twelve of them had unilateral
peripheral paralysis of the seventh cranial nerve; two, bilateral facial nerve
paralysis; and three, paralysis of the sixth cranial nerve. Moderate deafness
developed in two patients. Cranial nerve pareses often disappeared spontaneously
within a few weeks.
One 61-year-old woman slowly developed spastic paraparesis. Another patient, a
TABLE 1
Symptoms and Signs in 35 Patients with Chronic Meningitis



















bParaparesis: spastic type (one), lower-motor-neuron type (one),
partial paralysis ofone leg (two) or ofarms (one), hemiparesis (two)
cAtaxia (one), diplopia (two), somnolence (one)
49357-year-old man, experienced the rapid onset of lower-motor-neuron paraparesis.
Paresis of the proximal muscles of the left leg appeared in a 72-year-old man and a
64-year-old woman. Partial paralysis ofthe arms developed in a75-year-old man. A
left-sided hemiparesis developed slowly in a 70-year-old woman about six months
after the acute onset of headache, malaise, and weight loss. Finally, a 56-year-old
woman also developed hemiparesis. Other neurological signs included paresthesia
and hyperesthesia with different localizations. Seven patients had impairment of
sensation localized to one or more thoracic or lumbar segments. Six patients had
transient neck stiffness. Only one patient had slight clinical evidence ofencephalitis
with somnolence, and no patient had papilledema.
After treatment, 21 patients were followed for seven months to eight years (mean,
3.2 years); and the 14 patients from 1983, two to five months. Most symptoms and
neurological signs showed rapid regression. The spastic paraparesis in the
61-year-old woman showed some regression. The flaccid paraparesis in the
57-year-old man disappeared within four months. The unilateral paresis of leg
muscles in the 64-year-old woman and the 72-year-old man also disappeared within
a few months. The left-sided hemiparesis of the 70-year-old woman showed
moderate regression, as did the hemiparesis of the 56-year-old woman. There were
no other sequelae and no relapses.
Laboratory Findings
Seven patients had slight or moderate elevations of erythrocyte sedimentation
rates (maximum 47 mm/hour); a few cases had slight elevations ofliver transferases,
and hemoglobin and creatine were normal.
CSFAnalyses One hundred and eighty-seven lumbar punctures were done in
the 35 patients, 97 before treatment with penicillin G and 90 after (Table 2). The
highest measured CSF leucocyte count was 1,100 cells/mm3. The percentage of
mononuclear cells was usually more than 90 percent and often 98 to 100 percent.
Only three patients had values below 50 percent, the lowest being 44 percent. After
treatment with penicillin G, the CSF leucocyte counts fell, in some cases to normal.
Before treatment, the CSF protein was 0.6 to 13.0 g/l (mean, 2.35 g/l); after treat-
ment, the levels were lower or normal. The lowest value for the CSF/blood glucose
ratio was 0.2 (CSF glucose being 1.2 g/l). Before treatment, the glucose ratios were
low (0.2-0.4) in half of the patients and normal (20.5) in the others. After treat-
ment, the values were usually above 0.5.
Before treatment, almost all CSF samples showed several pronounced oligoclonal
immunoglobulin bands, determined by agarose electrophoresis and immunofixation
(Table 2). The striking changes in CSF samples contrasted with the modest findings
in the corresponding serum samples. The CSF-IgG index values were also increased,
indicating intrathecal synthesis of IgG. After treatment, the immune response in
CSF regressed very slowly. At long-term follow-up (mean, 2.2 years after
treatment), eight of20 patients had no demonstrable oligoclonal IgG bands, and all
had normal CSF-IgG index values. Most ofthe other patients had only weak indica-
tions of oligoclonal immunoglobulin bands.
Microbiological and Serologic Tests All bacteriological cultures of samples
taken from CSF, blood, and urine were negative, as were all tests for viruses,
mycobacteria, and fungi, and all serological tests for Treponemapallidum, Listeria
monocytogenes, Toxoplasma gondii, Leptospira, andActinomyces israelii. Antigen
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TABLE 2
Leucocytes, Glucose Ratios, and Proteins in CSF Specimens Sampled Initially, Before, and After
Treatment with Penicillin G, and at Long-Term Follow-up
Before After Long-term
Initial penicillin G penicillin G follow-up
Time before treatment:
Mean 6.0 wk
Range 1-22 wk 1-2 wk
Time after treatment:
Mean 2.2 yr
Range 1-4 wk 1 mo-6 yr
Spinal leucocytes
(x 106):
Mean 237 294 45 3
Range 36-412 66-840 2-180 0-28
Mononuclear cells >900/
(n/n tested) 22/25 29/35 33/35 16/21
CSF-glucose/blood-
glucose ratio 0.2-0.4
(n/n tested) 8/24 16/35 3/35 0/21
Spinal protein (g/l):
Mean 2.20 2.35 1.02 0.49
Range 0.7-9.8 0.6-13.0 0.4-4.9 0.3-1.0
Oligoclonal IgG bands
(agarose electrophoresis):
Pronounced 24/25 34/35 31/33 0/20
Weak 1/25 1/35 1/33 12/20
Absent 0/25 0/35 1/33 8/20
CSF-IgG index:"
Mean 1.2 1.29 1.06 0.57
Range 1.0-1.3 0.6-3.7 0.5-2.46 0.34-0.97
No. tested 4 30 19 18
,Normal range, 0.37-0.58
ofStreptococcus milleriwas detected in one of20 CSF samples before treatment but
not in a sample taken five weeks after treatment. Indirect immunofluorescence an-
tibody titers against the Lyme spirochete and the Swedish Ixodes ricinus spirochete
of > 160 were demonstrated in 26 of 34 chronic meningitis patients, but in only two
of 26 control cases of acute meningoencephalitis. We found concordant results be-
tween the two spirochetes.
Imprint Immunofixation In one patient with chronic meningitis, local in-
trathecal synthesis of spirochetal antibodies was demonstrated in all four CSF
samples collected during one year. Oligoclonal spirochete IgG antibodies appeared
as bands in the autoradiographs (Fig. 1). Intrathecal synthesis of Treponema reiter,
measles, or cytomegalovirus antibodies was not detected. In a patient with subacute
sclerosing panencephalitis (SSPE), local intrathecal synthesis of oligoclonal measles
virus antibodies was demonstrated (Fig. 1) but no local synthesis of antibodies to
spirochete, Treponema, or varicella zoster virus was found. The other control pa-
tient with acute meningoencephalitis had no demonstrable intrathecal antibodies
against any of these agents (Fig. 1).
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FIG. 1. Characterization ofantibodies by electrofocusing (pH 6.5-9.5) and imprint immunofixation in
(left to right) a patient with chronic meningitis (indirect immunofluorescence antibodytiters: serum 1,280
and CSF 320), a patient with subacute sclerosing panencephalitis (SSPE), and a patient with chronic me-
ningoencephalitis of unknown etiology. Each set ofautoradiographs shows serum above and CSF below.
Note presence ofoligoclonal CSF IgG in all three patients and ofintrathecally synthesized antibodies to
Lyme spirochete in the chronic meningitis patient and to measles virus in the SSPE patient.
DISCUSSION
The etiology of chronic meningitis is often difficult to determine [2]. The more
common causes include mycobacterial, bacterial, fungal, and other infectious or
non-infectious disorders [1]. Infections such as actinomycosis, nocardiosis, syphilis,
leptospirosis, and brucellosis can be complicated by chronic meningitis. However,
based on the antibody response against the Lyme spirochete and the Swedish L
ricinus spirochete, we have now demonstrated a spirochetal etiology for many cases
of chronic meningitis observed in Sweden.
The patients in our series had intrathecal synthesis of considerable quantities of
oligoclonal IgG. Oligoclonal IgG in CSF is demonstrable in multiple sclerosis and in
various infectious diseases of the central nervous system such as neurosyphilis,
measles encephalitis, herpes simplex encephalitis, and mumps meningoencephalitis
[9,10,11]. Moreover, we demonstrated local synthesis in the CSF of oligoclonal
spirochete-specific IgG. Local production of these specific antibodies strongly sup-
ports a direct relationship between spirochetal infection and chronic meningitis.
Many patients reported here had persistent or progressive symptoms and CSF ab-
normalities, which often lasted for months. They responded to intravenous
penicillin. Neurological involvement has been described after ECM by Bannwarth in
1941 and 1944 and by Horstrup and Ackermann in 1973, and named tick-borne
meningopolyneuritis [12,13,14]. Some of our patients shared characteristics with
those described for tick-borne meningopolyneuritis, but others in our series lacked
radicular pain and had a more slowly progressive disease accompanied by profound
fatigue, malaise, and considerable weight loss. Neurological abnormalities of Lyme
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disease, first reported in the United States in 1979 [15], include aseptic meningitis,
encephalitis, chorea, cerebellar ataxia, cranial neuropathy (including bilateral facial
paralysis), motor and sensory peripheral radiculoneuritis, mononeuritis multiplex,
and myelitis. In contrast, encephalitis is rare in European patients with ECM-
associated neurological disorders and in our chronic meningitis patients.
We have cultivated spirochetes from about 20 percent of collected I. ricinus ticks
[unpublished data]. These and other spirochete isolates will allow us to determine
the natural history of this tick-borne spirochetosis in Sweden. For example, we
know that chronic meningitis and ECM are parts ofthis illness, but cardiac and ar-
thritic complications are not reported from Sweden. The future will show us ifthese
complications do not occur there or have simply not yet been recognized.
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